Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Workers - Hazard via inhalation route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
0.1 mg/m³
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Workers - Hazard via dermal route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
0.03 mg/kg bw/day
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
Oral
DNEL related information
Explanation for the modification of the dose descriptor starting point:
No reliable and relevant long-term dermal study available
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
low hazard (no threshold derived)
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified

Workers - Hazard for the eyes

Local effects

Hazard assessment conclusion:
medium hazard (no threshold derived)

Additional information - workers

Worker

Hazard via dermal route - systemic - long-term

Hazard assessment of the substance is based on the most hazardous component, lead. NOEL from rat chronic feeding study of the lead acetate is used to derive DNEL.

Relevant dose descriptor for the endpoint

NOEL = 0.0015 mg/kg bw/day for lead ion, chronic exposure, oral gavage, rat by Krasovkii (1979)

Modification of the dose descriptor according to ECHA Guidance R.8 (November 2012) Example B.

Route of exposure (oral vs dermal); bioavailability is assumed to be 100% after oral gavage in mice. The skin absorption is assumed to be 0.1% in humans. The bioavailability of lead is based on observation that dermal absorption was 0.1% in in vitro dermal absorption study (Toner and Roper, 2005)

Corrected dermal NOAEL = oral NOAEL * (ABS oral-rat / ABS derm-rat) * (ABS derm-rat/ABS derm-human)

Corrected dermal NOAEL = oral NOAEL * ABSoral-rat / ABSderm-human                                                    

Corrected dermal NOAEL = 0.0015 mg/kg bw/day * (100/ 0.1) = 1.5 mg/kg bw/day

Assessment factors according to ECHA 2012 Guidance R.8 Characterization of dose response to human health

Allometric scaling; rat-human 4                                                 

Interspecies - remaining differences 2.5                                                               

Intraspecies – workers 5                                                              

Exposure duration - chronic study 1                                                        

Issues related to dose responses - the starting point for the DNEL calculation is a derived NOAEL - default assessment factor 1                                                

Quality of whole database - default assessment factor 1

Overall AF: 4 x 2.5 x 5 x 1 x 1 x 1 = 50

DNEL worker chronic systemic by dermal route = 1.5 mg/kg bw/day / 50 = 0.03 mg/kg bw/day  

                                                              

                                                                                                                                                                              

General Population - Hazard via inhalation route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
500 ng/m³
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

General Population - Hazard via dermal route

Systemic effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified

General Population - Hazard via oral route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
0.004 mg/kg bw/day
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

General Population - Hazard for the eyes

Local effects

Hazard assessment conclusion:
no hazard identified

Additional information - General Population

General population

Hazard via oral route – systemic – long-term effects

Meta-analyses of human observational epidemiology data show a statistical association between post-natal blood lead and IQ that is small and most likely between a one to three IQ point deficit for a change in mean blood lead level from 10 µg/dL to 20 µg/dL. Any IQ decrements that might occur at blood lead levels below 10 µg/dL would not be detectable in the individual. Although such effects may lack significance for the individual, an impact upon large numbers of children may have societal significance. 

However, observational data suggests that population effects in children may occur at blood lead levels as low as 5 µg/dL. Designation of 5 µg/dL as an epistemic threshold and a “societal blood lead target” also dramatically reduce the probability that individual children might exceed a blood lead level of 10 µg/dL. Thus, for purposes of Risk Characterisation, NOAEL of 5 µg/dL is used to minimize the probability that individual blood lead levels will exceed 10 µg/dL.

Conversion of NOAEL to DNEL.

NOAEL 5 µg lead /dL = 50 µg / L (for large populations of children).

Weight of a child: 20 kg. (European Commission (2001), Guidance on exposure estimation)

Total blood volume in children is 75-80 ml/kg. WHO (2010), Blood sample volumes in child health research: review of safe limits.

Thus, the blood volume of a child is 80 ml/kg * 20 kg = 1600 ml = 1.6 L

Total amount of lead in blood: 50 µg / L * 1,6 L = 80 µg.

DNEL for daily dose (lead in blood per body weight): 80 µg / 20 kg = 4 ug / kg bw = 0.004 mg lead/kg bw